TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Drugs AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
30,419
|
26,965
|
23,472 |
Financial expenses |
1
|
7
|
11 |
Earnings before taxes |
1,343
|
-267
|
-335 |
EBITDA |
1,271
|
-353
|
-433 |
Total assets |
15,337
|
12,499
|
14,515 |
Current assets |
15,238
|
12,283
|
14,160 |
Current liabilities |
6,078
|
4,126
|
4,864 |
Equity capital |
8,823
|
7,941
|
9,024 |
- share capital |
1,802
|
1,797
|
1,956 |
Employees (average) |
25
|
26
![]() |
26 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
57.5%
|
63.5%
|
62.2% |
Turnover per employee |
1,217
|
1,037
|
903 |
Profit as a percentage of turnover |
4.4%
|
-1.0%
|
-1.4% |
Return on assets (ROA) |
8.8%
|
-2.1%
|
-2.2% |
Current ratio |
250.7%
|
297.7%
|
291.1% |
Return on equity (ROE) |
15.2%
|
-3.4%
|
-3.7% |
Change turnover |
3,375
|
5,395
|
-4,497 |
Change turnover % |
12%
|
25%
|
-16% |
Chg. No. of employees |
-1
|
0
|
-1 |
Chg. No. of employees % |
-4%
|
0%
|
-4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.